Table 7. Outcome of patients with autoimmune hepatitis-related acute-on-chronic liver failure.
ALP: alkaline phosphatase; ALT: alanine aminotransferase; AST: aspartate aminotransferase; IgG: immunoglobin G; INR: international normalized ratio
| Patient characteristics | Male (n=4) | Female (n=6) |
| Age | 42 (35-54) | 46 (31-59) |
| Hemoglobin (g/dL) | 9 (7.7-12.6) | 12 (9.2-12.2) |
| Total leukocyte count (per/mm3) | 6850 (3800-11500) | 5250 (2881-8000) |
| Platelet count (lacs/mm3) | 1.31 (1.05-1.61) | 1.37 (1.25-1.58) |
| Total Bilirubin mg/ dL | 18 (6.5-26) | 20 (1.4-23) |
| Conjugated Bilirubin | 12 (3.9-18) | 15.2 (6.1-18.2) |
| AST (U/L) | 182 (157-389) | 89 (52-288) |
| ALT (U/L) | 134 (102-223) | 115 (32-209) |
| ALP (U/L) | 112 ( 156-273) | 137 (102-312) |
| Albumin (g/dL) | 2.7 (2.5-3.65) | 2.5 ( 2.3-4.0) |
| Protein | 7.8 (7.2-7.77) | 7.4 (5.8-8.0) |
| IgG | 2640 (2177-3260) | 2680 (2020-2910) |
| INR | 1.7 (1.3-3.9) | 1.82 (1.12-2.16) |
| Outcome | Male (n=4) | Female (n=4) |
| Remission | 25% (1/4) | 50% (3/6) |
| Mortality | 50% (2) | 33% (2/6) |
| Relapse | 100% (2/2) | 50% (2/4) |